BIONTECH: With overwhelming efficacy at interim look, COVID vaccine is progressing to the final point | BUY | USD98 vs. USD93 (-6%)
BIONTECH - BUY | USD98 vs. USD93 (-6%)With overwhelming efficacy at interim look, COVID vaccine is progressing to the final point
Interim look shows better-than-expected efficacy of BNT162b2
Anticipating filing for EUA to be on track for November end
Valuation - TP increased
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.